BPC-157
Body Protection Compound
Repair & Recovery
Subcutaneous
4w on / 2w off
Often split AM/PM for gut protocols, or injected near the site of injury for local repair.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 250 mcg dose = 0.1 mL
TB-500
Thymosin Beta-4 fragment
Repair & Recovery
Typical dose
2–2.5 mg loading, 2.5–5 mg maintenance
Subcutaneous
6w on / 2w off
Loading phase twice weekly for 4–6 weeks, then maintenance every 2–4 weeks.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 2.5 mg dose = 1 mL
Ipamorelin
GH Secretagogue
Subcutaneous
8w on / 4w off
Commonly stacked with CJC-1295 (no DAC). Take fasted; avoid food 2h before / 30 min after.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 250 mcg dose = 0.1 mL
CJC-1295 (no DAC)
Mod GRF 1-29
GH Secretagogue
Subcutaneous
8w on / 4w off
Short-acting GHRH analog, usually dosed AM fasted and pre-bed.
At 2 mg in 2 mL → 1 mg/mL · 10 mcg per unit · one 100 mcg dose = 0.1 mL
CJC-1295 with DAC
GH Secretagogue
Subcutaneous
8w on / 4w off
Long-acting; dosed once or twice weekly rather than daily.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 2 mg dose = 0.8 mL
Sermorelin
GH Secretagogue
Subcutaneous
12w on / 4w off
Dosed at bedtime to align with the natural nocturnal GH pulse.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 250 mcg dose = 0.1 mL
Subcutaneous
4w on / 4w off
Cycled tightly — receptor desensitization is the main reason for short cycles.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 150 mcg dose = 0.06 mL
Tesamorelin
GH Secretagogue
Approved prescribing dose for HIV-associated lipodystrophy is 2 mg daily.
At 2 mg in 2 mL → 1 mg/mL · 10 mcg per unit · one 2 mg dose = 2 mL
Typical dose
0.25 → 2.4 mg
Titration: 0.25 mg wk 1–4 → 0.5 → 1.0 → 1.7 → 2.4 mg, stepping every 4 weeks
Weekly dosing with a 4-week titration ladder mirroring approved prescribing information.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 250 mcg dose = 0.1 mL
Titration: 2.5 mg wk 1–4 → 5 → 7.5 → 10 → 12.5 → 15 mg, stepping every 4 weeks
Dual GIP/GLP-1 agonist; weekly with a 4-week titration ladder.
At 30 mg in 2 mL → 15 mg/mL · 150 mcg per unit · one 2.5 mg dose = 0.167 mL
Titration: Trial escalation: 1 mg → 2 mg → 4 mg every 4 weeks
Investigational triple agonist; dose ranges are the least standardized on this list.
At 10 mg in 2 mL → 5 mg/mL · 50 mcg per unit · one 1 mg dose = 0.2 mL
Subcutaneous
8w on / 2w off
Commonly run 5-on / 2-off, dosed fasted in the morning.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 300 mcg dose = 0.12 mL
Subcutaneous
4w on / 4w off
Mitochondrial-derived peptide; commonly 2–3x weekly or on a fixed interval such as every 5 days, in short blocks.
At 10 mg in 2 mL → 5 mg/mL · 50 mcg per unit · one 5 mg dose = 1 mL
Thymosin Alpha-1
Immune & Longevity
Subcutaneous
8w on / 4w off
Often a loading phase twice weekly, then tapered.
At 10 mg in 2 mL → 5 mg/mL · 50 mcg per unit · one 1.5 mg dose = 0.3 mL
Subcutaneous
2w on / 24w off
Classic Khavinson pattern: a 10–20 day course, one or two courses per year.
At 50 mg in 5 mL → 10 mg/mL · 100 mcg per unit · one 5 mg dose = 0.5 mL
Default vial
500 mg / 10 mL
Subcutaneous / IM
4w on / 2w off
Inject slowly — rapid administration is the usual cause of flushing and chest tightness.
At 500 mg in 10 mL → 50 mg/mL · 500 mcg per unit · one 75 mg dose = 1.5 mL
Glutathione
Immune & Longevity
Default vial
1200 mg / 10 mL
IM / Subcutaneous
8w on / 2w off
Light-sensitive; keep the vial shielded from sunlight.
At 1200 mg in 10 mL → 120 mg/mL · 1,200 mcg per unit · one 400 mg dose = 3.333 mL
Subcutaneous
4w on / 4w off
Mitochondria-targeting peptide; trial ranges are wide.
At 50 mg in 2 mL → 25 mg/mL · 250 mcg per unit · one 10 mg dose = 0.4 mL
DSIP
Delta Sleep-Inducing Peptide
Neuro & Sleep
Subcutaneous
4w on / 2w off
Taken shortly before bed; some run it every other night.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 200 mcg dose = 0.08 mL
As-needed, 45 min–2 h before activity. Community guidance caps frequency at ~1 dose / 24–48 h.
At 10 mg in 2 mL → 5 mg/mL · 50 mcg per unit · one 1 mg dose = 0.2 mL
Kisspeptin-10
Neuro & Sleep
Typical dose
~1 mg (research: 25–100 mcg/kg)
Subcutaneous
4w on / 4w off
Mostly research protocols; dosing is weight-based in the literature.
At 5 mg in 2 mL → 2.5 mg/mL · 25 mcg per unit · one 1 mg dose = 0.4 mL
Typical dose
1–2 mg injectable, or 1–2% topical
Subcutaneous / topical
8w on / 2w off
Frequently used topically instead of injected. Copper peptide — keep away from light.
At 50 mg in 2 mL → 25 mg/mL · 250 mcg per unit · one 1.5 mg dose = 0.06 mL
Melanotan II
Cosmetic & Other
Subcutaneous
2w on / 2w off
Start at the low end and titrate. Degrades faster than most peptides — use within ~2–3 weeks of reconstitution.
At 10 mg in 2 mL → 5 mg/mL · 50 mcg per unit · one 250 mcg dose = 0.05 mL